|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang L, Liang J, Liu X, Wu J, Tan D and
Hu W: Aloperine exerts antitumor effects on bladder cancer in
vitro. Onco Targets Ther. 13:10351–10360. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jian Y, Xu Z, Xu C, Zhang L, Sun X, Yang D
and Wang S: The roles of glycans in bladder cancer. Front Oncol.
10:9572020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El-Hefnawy AS, Rizk E, Al Demerdash Khamis
NM, Barakat MAA, Khater SM and Shokeir AA: Urinary hyaluronic acid:
A versatile marker of bladder cancer. Int Urol Nephrol.
52:1691–1699. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dal Moro F, Valotto C, Guttilla A and
Zattoni F: Urinary markers in the everyday diagnosis of bladder
cancer. Urologia. 80:265–275. 2013. View Article : Google Scholar
|
|
6
|
Tao K, Liu S, Wang L, Qiu H, Li B, Zhang
M, Guo M, Liu H, Zhang X, Liu Y, et al: Targeted multifunctional
nanomaterials with MRI, chemotherapy and photothermal therapy for
the diagnosis and treatment of bladder cancer. Biomater Sci.
8:342–352. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Payumo AY and Huang GN: Lamin B2, guardian
of cardiomyocyte nuclear division. Dev Cell. 53:5–7. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ranade D, Koul S, Thompson J, Prasad KB
and Sengupta K: Chromosomal aneuploidies induced upon Lamin B2
depletion are mislocalized in the interphase nucleus. Chromosoma.
126:223–244. 2017. View Article : Google Scholar :
|
|
9
|
Kuga T, Nie H, Kazami T, Satoh M,
Matsushita K, Nomura F, Maeshima K, Nakayama Y, Tomonaga T and
Lamin B: 2 prevents chromosome instability by ensuring proper
mitotic chromosome segregation. Oncogenesis. 3:e942014. View Article : Google Scholar
|
|
10
|
Han L, Choudhury S, Mich-Basso JD,
Ammanamanchi N, Ganapathy B, Suresh S, Khaladkar M, Singh J, Maehr
R, Zuppo DA, et al: Lamin B2 levels regulate polyploidization of
cardiomyocyte nuclei and myocardial regeneration. Dev Cell.
53:42–59.e11. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Razafsky D, Ward C, Potter C, Zhu W, Xue
Y, Kefalov VJ, Fong LG, Young SG and Hodzic D: Lamin B1 and lamin
B2 are long-lived proteins with distinct functions in retinal
development. Mol Biol Cell. 27:1928–1937. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Parry DA, Martin CA, Greene P, Marsh JA;
Genomics England Research Consortium; Blyth M, Cox H, Donnelly D,
Greenhalgh L, Greville-Heygate S, et al: Heterozygous lamin B1 and
lamin B2 variants cause primary microcephaly and define a novel
laminopathy. Genet Med. 23:408–414. 2021. View Article : Google Scholar :
|
|
13
|
Galazis N, Olaleye O, Haoula Z, Layfield R
and Atiomo W: Proteomic biomarkers for ovarian cancer risk in women
with polycystic ovary syndrome: A systematic review and biomarker
database integration. Fertil Steril. 98:1590–1601.e1. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang MY, Han YC, Han Q, Liang Y, Luo Y,
Wei L, Yan T, Yang Y, Liu SL and Wang EH: Lamin B2 promotes the
malignant phenotype of non-small cell lung cancer cells by
upregulating dimethylation of histone 3 lysine 9. Exp Cell Res.
393:1120902020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kong W, Wu Z, Yang M, Zuo X, Yin G and
Chen W: LMNB2 is a prognostic biomarker and correlated with immune
infiltrates in hepatocellular carcinoma. IUBMB Life. 72:2672–2685.
2020. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma Y, Fei L, Zhang M, Zhang W, Liu X, Wang
C, Luo Y, Zhang H and Han Y: Lamin B2 binding to minichromosome
maintenance complex component 7 promotes non-small cell lung
carcinogenesis. Oncotarget. 8:104813–104830. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abdelbaqi K and Di Paola D: Ku protein
levels, localization and association to replication origins in
different stages of breast tumor progression. J Cancer. 4:358–370.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Cancer Genome Atlas Research Network:
Comprehensive molecular characterization of clear cell renal cell
carcinoma. Nature. 499:43–49. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hoadley KA, Yau C, Hinoue T, Wolf DM,
Lazar AJ, Drill E, Shen R, Taylor AM, Cherniack AD, Thorsson V, et
al: Laird, cell-of-origin patterns dominate the molecular
classification of 10,000 tumors from 33 types of cancer. Cell.
173:291–304.e6. 2018. View Article : Google Scholar
|
|
21
|
Zou RC, Guo ZT, Wei D, Shi ZT, Ye ZC, Zhai
G, Zhong C, Tang B, Wang L and Ge JY: Downregulation of CDCA3
expression inhibits tumor formation in pancreatic cancer.
Neoplasma. 67:1223–1232. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qian W, Zhang Z, Peng W, Li J, Gu Q, Ji D,
Wang Q, Zhang Y, Ji B, Wang S, et al: CDCA3 mediates p21-dependent
proliferation by regulating E2F1 expression in colorectal cancer.
Int J Oncol. 53:2021–2033. 2018.PubMed/NCBI
|
|
23
|
Nguyen EK, Yu H, Pond G, Shayegan B,
Pinthus JH, Kapoor A, Mukherjee SD, Neville A, Lalani AA, Hotte SJ,
et al: Outcomes of trimodality bladder-sparing therapy for
muscle-invasive bladder cancer. Can Urol Assoc J. 14:122–129.
2020.
|
|
24
|
Pearce S and Daneshmand S: Enhanced
endoscopy in bladder cancer. Curr Urol Rep. 19:842018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
De Keukeleire S, De Maeseneer D, Jacobs C
and Rottey S: Targeting FGFR in bladder cancer: Ready for clinical
practice? Acta Clin Belg. 75:49–56. 2020. View Article : Google Scholar
|
|
26
|
Vartolomei L, Ferro M, Mirone V, Shariat
SF and Vartolomei MD: Systematic review: Depression and anxiety
prevalence in bladder cancer patients. Bladder Cancer. 4:319–326.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Coffinier C, Fong LG and Young SG: LINCing
lamin B2 to neuronal migration: Growing evidence for cell-specific
roles of B-type lamins. Nucleus. 1:407–411. 2010. View Article : Google Scholar
|
|
28
|
Hegele RA, Cao H, Liu DM, Costain GA,
Charlton-Menys V, Rodger NW and Durrington PN: Sequencing of the
reannotated LMNB2 gene reveals novel mutations in patients with
acquired partial lipodystrophy. Am J Hum Genet. 79:383–389. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Damiano JA, Afawi Z, Bahlo M, Mauermann M,
Misk A, Arsov T, Oliver KL, Dahl HH, Shearer AE, Smith RJ, et al:
Mutation of the nuclear lamin gene LMNB2 in progressive myoclonus
epilepsy with early ataxia. Hum Mol Genet. 24:4483–4490. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Puzzi L, Marchetti L, Peverali FA,
Biamonti G and Giacca M: DNA-protein interaction dynamics at the
Lamin B2 replication origin. Cell Cycle. 14:64–73. 2015. View Article : Google Scholar :
|
|
31
|
Giusti L, Da Valle Y, Bonotti A, Donadio
E, Ciregia F, Ventroni T, Foddis R, Giannaccini G, Guglielmi G,
Cristaudo A and Lucacchini A: Comparative proteomic analysis of
malignant pleural mesothelioma evidences an altered expression of
nuclear lamin and filament-related proteins. Proteomics Clin Appl.
8:258–268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang Y, Yin W, Cao W, Chen P, Bian L and
Ni Q: CDCA3 is a potential prognostic marker that promotes cell
proliferation in gastric cancer. Oncol Rep. 41:2471–2481.
2019.PubMed/NCBI
|
|
33
|
Adams MN, Burgess JT, He Y, Gately K,
Snell C, Zhang SD, Hooper JD, Richard DJ and O'Byrne KJ: Expression
of CDCA3 is a prognostic biomarker and potential therapeutic target
in non-small cell lung cancer. J Thorac Oncol. 12:1071–1084. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang W, Lu Y and Li X, Zhang J, Zheng L,
Zhang W, Lin C, Lin W and Li X: CDCA3 promotes cell proliferation
by activating the NF-κB/cyclin D1 signaling pathway in colorectal
cancer. Biochem Biophys Res Commun. 500:196–203. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li S, Liu X, Liu T, Meng X, Yin X, Fang C,
Huang D, Cao Y, Weng H, Zeng X and Wang X: Identification of
biomarkers correlated with the TNM staging and overall survival of
patients with bladder cancer. Front Physiol. 8:9472017. View Article : Google Scholar : PubMed/NCBI
|
